Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07112196
PHASE2/PHASE3

Visugromab in Cachexia International Trial

Sponsor: CatalYm GmbH

View on ClinicalTrials.gov

Summary

A study of how well and safely a new drug called visugromab works in people with certain kinds of cancer (including lung and bowel cancer) and unintended weight loss known as cachexia. The main questions it aims to answer are: * Does visugromab help participants put weight back on and have a better appetite? * Does visugromab help participants move more and better? * What medical problems do participants have when taking visugromab? Researchers will compare visugromab to a placebo (a look-alike substance that contains no drug). Participants will visit the hospital or clinic once every 4 weeks to receive visugromab or placebo via a drip into a vein and to undergo checkups and tests.

Official title: Adaptive, Phase 2/3, Randomized, Double-Blind Trial Investigating the Efficacy and Safety of Visugromab Versus Placebo in Patients With Cancer-associated Cachexia

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

518

Start Date

2026-04-16

Completion Date

2030-12

Last Updated

2026-05-20

Healthy Volunteers

No

Interventions

DRUG

Visugromab (CTL-002)

High dose

DRUG

Placebo

IV infusion

DRUG

Visugromab (CTL-002)

Medium dose

DRUG

Visugromab (CTL-002)

Low dose

Locations (34)

Clermont Oncology Center

Clermont, Florida, United States

Mid Florida Hematology and Oncology Centers

Orange City, Florida, United States

Cleveland Clinic Avon Hospital

Avon, Ohio, United States

Cleveland Clinic (Main Campus)

Cleveland, Ohio, United States

Cleveland Clinic Fairview Hospital

Fairview, Ohio, United States

Cleveland Clinic Hillcrest Hospital

Mayfield Heights, Ohio, United States

Specialized Hospital for Active Treatment in Oncology

Haskovo, Bulgaria

Medical Centre Futuremeds Plovdiv

Plovdiv, Bulgaria

Multiscan, s.r.o., Nemocnice Horovice

Hořovice, Czechia

Léon Bérard Center (Centre Léon Bérard)

Lyon, France

University Hospital Carl Gustav Carus Dresden (Universitätsklinikum Carl Gustav Carus Dresden)

Dresden, Germany

ASST degli Spedali Civili di Brescia

Brescia, Italy

Azienda Ospedaliero-Universitaria di Ferrara-Arcispedale Sant'Anna

Ferrara, Italy

Centro Ricerche Cliniche di Verona

Verona, Italy

Oslo University Hospital

Oslo, Norway

Akershus University Hospital

Oslo, Norway

Pratia Onkologia Katowice

Katowice, Poland

Jagiellońskie Centrum Innowacji Sp. z o.o.

Krakow, Poland

Futuremeds Łódź

Lodz, Poland

Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi.

Lodz, Poland

MS CLINSEARCH Specjalistyczny NZOZ Janusz Milanowski, Katarzyna Szmygin - Milanowska Sp. j.

Lublin, Poland

FutureMeds Targówek

Warsaw, Poland

Pratia Onkologia Wrocław

Wroclaw, Poland

Oncolab Craiova

Craiova, Romania

St. Nectarie Oncology Center, Craiova

Craiova, Romania

University Hospital of A Coruña (Hospital Universitario de A Coruña)

A Coruña, Spain

Futuremeds Hospital Viamed Santa Elena

Madrid, Spain

Hospital Universitario Puerta de Hierro

Majadahonda, Spain

Gruppo Ospedaliero Moncucco - Clinica Moncucco

Lugano, Switzerland

Cantonal Hospital St. Gallen (Kantonsspital St. Gallen)

Sankt Gallen, Switzerland

University Hospital of Zurich (Universitätsspital Zürich)

Zurich, Switzerland

Royal Sussex County Hospital

Brighton, United Kingdom

Ninewells Hospital

Dundee, United Kingdom

Royal Surrey County Hospital

Guildford, United Kingdom